Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Venous Thromboembolism × betrixaban × Classical hematology × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 1

Interventions

apixaban 18 Rivaroxaban 15 Dalteparin 15 Enoxaparin 10 Tinzaparin 8 Heparin, Low-Molecular-Weight 8 Aspirin 7 Fondaparinux 4 Dabigatran 4 edoxaban 3 Warfarin 3 bemiparin 2 abelacimab 2 Rosuvastatin Calcium 2 Observation 2 Nadroparin 2 MAA868 2 sotorasib 1 ribociclib 1 reviparin 1 palbociclib 1 enoxaparin sodium 1 certoparin 1 calcium heparin 1 betrixaban 1 argatroban 1 acarboxyprothrombin 1 abemaciclib 1 Tacrolimus 1 Tablets 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01583218 2023-08-07

APEX

Alexion Pharmaceuticals, Inc.

Phase 3 Completed

7,513 enrolled 18 charts 1 FDA

Classical hematology

Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡